###begin article-title 0
The p110delta of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation
###end article-title 0
###begin p 1
###xml 40 59 40 59 <email xmlns:xlink="http://www.w3.org/1999/xlink">subra.malar@bcw.edu</email>
CORRESPONDENCE Subramaniam Malarkannan: subra.malar@bcw.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 260 265 256 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A</sup>
###xml 421 425 413 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 700 711 684 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 859 870 839 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
Phosphatidylinositol 3-kinases (PI3Ks) play a critical role in regulating B cell receptor- and T cell receptor-mediated signaling. However, their role in natural killer (NK) cell development and functions is not well understood. Using mice expressing p110deltaD910A, a catalytically inactive p110delta, we show that these mice had reduced NK cellularity, defective Ly49C and Ly49I NK subset maturation, and decreased CD27High NK numbers. p110delta inactivation marginally impaired NK-mediated cytotoxicity against tumor cells in vitro and in vivo. However, NKG2D, Ly49D, and NK1.1 receptor-mediated cytokine and chemokine generation by NK cells was severely affected in these mice. Further, p110deltaD910A/D910A NK cell-mediated antiviral responses through natural cytotoxicity receptor 1 were reduced. Analysis of signaling events demonstrates that p110deltaD910A/D910A NK cells had a reduced c-Jun N-terminal kinase 1/2 phosphorylation in response to NKG2D-mediated activation. These results reveal a previously unrecognized role of PI3K-p110delta in NK cell development and effector functions.
###end p 3
###begin p 4
###xml 54 69 <span type="species:ncbi:10029">Chinese hamster</span>
Abbreviations used: 7-AAD, 7-aminoactinomycin D; CHO, Chinese hamster ovary; ERK, extracellular signal-regulated kinase; HA, hemagglutinin; ITAM, immunoreceptor tyrosine-based activation motif; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; MIP, macrophage inflammatory protein; MOI, multiplicity of infection; NCR, natural cytotoxicity receptor; NKP, NK precursor; PI3K, phosphatidylinositol 3-kinase; PTK, protein tyrosine kinase; RANTES, regulated upon activation, normal T cell expressed and secreted; YINM, Tyr-Ile-Asn-Met.
###end p 4
###begin p 5
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 531 532 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 578 579 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 619 620 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 645 646 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 768 769 747 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 770 772 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 962 963 941 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 1133 1134 1112 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 1135 1137 1114 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 1226 1228 1205 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 1230 1232 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 1337 1338 1316 1317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 1340 1342 1319 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 478 483 <span type="species:ncbi:9606">human</span>
###xml 488 493 <span type="species:ncbi:10090">mouse</span>
###xml 553 559 <span type="species:ncbi:9606">humans</span>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
###xml 1245 1250 <span type="species:ncbi:10090">mouse</span>
NK cells are an important component of innate immunity, capable of mediating cytotoxicity against tumor and virus-infected cells. Effector functions of NK cells are regulated by the coordinated interaction of activating and inhibitory receptors (1). Determining precise signaling events downstream of these receptors is paramount for successful clinical utilization of NK cells. One of the activating receptors, NKG2D, is a lectin type II transmembrane protein expressed on all human and mouse NK cells, and it recognizes MIC-A/B (2) and ULBP-1/2/3 (in humans) (3), and H60 (4, 5), Rae-1alpha/beta/gamma/delta/epsilon (5), and Mult-1 (in mice) (6). Upon activation, NKG2D employs Src family protein tyrosine kinases (PTKs) to initiate two distinct signaling pathways (7-11), leading to effector functions. In the first pathway, activated PTK phosphorylates Tyr-Ile-Asn-Met (YINM) motif-bearing DAP10, which in turn recruits phosphatidylinositol 3-kinase (PI3K) (9). In the second pathway, PTK phosphorylates the immunoreceptor tyrosine-based activation motif (ITAM)-containing KARAP/DAP12, which subsequently triggers Syk and ZAP70 (8-11). Another major activating receptor, Ly49D, which associates with both DAP10 and DAP12 (12, 13), is also a mouse lectin type II transmembrane protein, which interacts with classical MHC class I, H2-Dd (14).
###end p 5
###begin p 6
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 319 321 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 337 339 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 386 388 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 548 550 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 623 625 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 825 827 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 895 897 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 1000 1002 989 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 1201 1203 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 1345 1346 1334 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 1347 1349 1336 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 175 180 <span type="species:ncbi:9606">human</span>
###xml 230 235 <span type="species:ncbi:10090">mouse</span>
###xml 534 546 <span type="species:ncbi:11191">Sendai virus</span>
Natural cytotoxicity receptors (NCRs) are immunoglobulin-like transmembrane glycoproteins that recognize unknown ligands on several tumor cells. The NCR family contains three human (NKp46/NCR1, NKp44/NCR2, and NKp30/NCR3) and one mouse (NKp46/NCR1) members (15-18). NKp46 and NKp30 associate with ITAM-bearing CD3zeta (17) and FCRgamma (19), respectively, whereas NKp44 recruits DAP12 (20). Although cellular ligands for NCRs have not been found, NCR1 is known to interact with hemagglutinin (HA) of influenza and HA-neuraminidase of Sendai virus (21). NK1.1 (Nkrp1c) is a unique cell marker expressed on NK and NKT cells (22). Although the activating ligands for Nkrp1c have yet to be determined, the inhibitory ligands for its related family members Nkrp1d and Nkrp1f have been defined as the Clr family of C-type lectins (23). NK1.1 physically associates with FcRgamma to mediate its signal (24). Several NK inhibitory receptors have been identified, such as KIR, Ly49A, Ly49C, Ly49G2, and Ly49I (25). These inhibitory receptors recognize classical MHC class I molecules. Upon interaction, they recruit phosphatases to the immunoreceptor tyrosine-based inhibitory motif in the cytoplasmic domains (26). Thus, NK cells use a complex set of receptors and signaling pathways to achieve their intended effector functions. Despite recent studies (8-13) that have provided deeper insights regarding the activation pathways, multiple knowledge gaps exist, hindering comprehensive clinical applications of NK cells.
###end p 6
###begin p 7
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 355 357 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 504 506 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 508 510 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 618 620 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 622 624 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 938 949 888 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 957 959 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 986 989 936 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink">910</sup>
###xml 1253 1255 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
###xml 787 791 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 950 954 <span type="species:ncbi:10090">mice</span>
Class I PI3Ks generate secondary lipid messengers that regulate a wide array of intracellular signaling pathways in numerous cell types (27). Several isoforms of regulatory p85 (p85alpha, p55alpha, p50alpha, p85beta, and p55gamma) and catalytic p110 (p110alpha, p110beta, p110gamma, and p110delta) subunits have been described to play distinct functions (27). For example, mice lacking the p85alpha regulatory or p110delta catalytic subunit show severely impaired B and T cell development and functions (28, 29). Deletion of individual catalytic or regulatory subunits results in altered expression of other subunits (30, 31). Thus, use of gene KO mice precludes proper evaluation of the PI3K isoform-selective functions in lymphocytes. To avoid these inherent complications in using KO mice, we generated mice with a point mutation that completely inactivated the catalytic function of p110delta subunit (further referred to as p110deltaD910A/D910A mice) (32). This point mutation, Asp910-->Ala (D910A), resulted in a complete loss-of-function locus but retained the normal expression levels of p110delta protein. More importantly, this strategy did not result in any compensatory increase of p110alpha, p110beta, and total p85 subunits in thymocytes (32).
###end p 7
###begin p 8
###xml 34 45 30 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 172 183 160 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 393 404 377 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 660 671 636 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 723 734 695 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1001 1012 969 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
In this study, using the p110deltaD910A/D910A mice, we demonstrate that PI3K-p110delta plays a pivotal role in the development and effector functions of NK cells. p110deltaD910A/D910A mice had reduced NK cellularity and a selective impairment in the maturation of Ly49C and Ly49I NK subsets. Further, mature NK cell populations, as defined by CD27 and CD11b, were markedly altered in p110deltaD910A/D910A mice. p110delta inactivation marginally impaired NK cell-mediated cytotoxicity against tumor and virally infected cells. However, NKG2D, Ly49D, and NK1.1 receptor-mediated cytokine and chemokine generation were severely impaired in NK cells from p110deltaD910A/D910A mice. In addition, cytokine generation by p110deltaD910A/D910A NK cells in response to virally infected cells was markedly reduced. Biochemical analysis indicates that defects in the activation and phosphorylation of the c-Jun N-terminal kinase (JNK) pathway could be responsible for the impaired cytokine generation in p110deltaD910A/D910A NK cells. Our results demonstrate that the PI3K-p110delta subunit plays a crucial role in NK cellularity, terminal maturation, and cytokine/chemokine generation.
###end p 8
###begin title 9
RESULTS
###end title 9
###begin title 10
###xml 50 61 46 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Unaltered expression of PI3K subunits in p110deltaD910A/D910A mice
###end title 10
###begin p 11
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 263 265 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 416 418 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 420 422 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 536 547 506 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 620 628 590 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 a</xref>
###xml 921 932 872 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1171 1182 1106 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1215 1223 1150 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 a</xref>
###xml 1335 1346 1266 1277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1465 1467 1389 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 1716 1727 1621 1632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 933 937 <span type="species:ncbi:10090">mice</span>
###xml 1347 1351 <span type="species:ncbi:10090">mice</span>
###xml 1459 1463 <span type="species:ncbi:10090">mice</span>
###xml 1728 1732 <span type="species:ncbi:10090">mice</span>
The class I PI3K complex is primarily made up of p85 regulatory and p110 catalytic subunits. Altering expression of one subunit severely affects the expression of the others (31). p110alpha deletion resulted in significant overexpression of the p85alpha subunit (33). Similarly, deletion of p85alpha leads to an increased expression of p85beta and a dramatic decrease of p110alpha, p110beta, and p110delta subunits (28, 29). Therefore, we first analyzed the expression of distinct PI3K subunits in IL-2-activated NK cells from p110deltaD910A/D910A mice that were backcrossed with the C57BL/6 strain for N12 generations (Fig. 1 a). All p110 isoforms were detectable in NK cells derived from both spleen and BM, with the level of the inactive p110delta being similar to that in NK cells from C57BL/6 (WT/WT) mice. No compensatory expressions of p110alpha, p110beta, and p110gamma in NK cells from spleen and BM of p110deltaD910A/D910A mice were found. We also analyzed the presence of total p85 and p85alpha subunits with pan-anti-p85 and anti-p85alpha antibodies, respectively. Our results showed no alteration in the quantity of total p85 or p85alpha subunit in p110deltaD910A/D910A-derived splenic or BM NK cells (Fig. 1 a). These observations are consistent with our earlier studies, which demonstrated that thymocytes from p110deltaD910A/D910A mice contain similar expression levels of p110alpha, p110beta, and total p85 subunits compared with those of WT mice (32). Collectively, we conclude that the D910A mutation did not alter the protein expression levels of p110delta itself. Also, there were no alterations in the protein levels of p110alpha, p110beta, and p110gamma subunits in the NK cells from p110deltaD910A/D910A mice. Further, there were no changes in the levels of total p85 or p85alpha subunits because of the D910A mutation.
###end p 11
###begin p 12
###xml 40 51 36 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 0 57 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phenotypic characterization of p110&#948;<sup>D910A/D910A</sup> mice.</bold>
###xml 372 383 356 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 491 492 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 497 498 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 536 547 516 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 661 662 635 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 667 668 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 861 872 831 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 944 945 914 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 950 951 920 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
###xml 1098 1102 <span type="species:ncbi:10090">mice</span>
Phenotypic characterization of p110deltaD910A/D910A mice. (a) Expression levels of PI3K subunits were unaltered after the catalytic inactivation of p110delta. Expression of p110 and total p85 and p85alpha isoforms was analyzed by Western blotting in IL-2-activated splenic and BM NK cells. (b) Absolute numbers of spleen and BM cells are significantly reduced in p110deltaD910A/D910A mice. Total cellularity of the spleen and BM was calculated from 10 mice in each genotype. (c) Absolute CD3-NK1.1+ cell number is decreased in p110deltaD910A/D910A mice. Single-cell suspensions were stained with anti-NK1.1 and anti-CD3epsilon mAbs. NK cells as specified by CD3-NK1.1+ positivity were gated and analyzed for absolute numbers. Data shown were obtained using cells from seven mice of each genotype. (d) Expression of early developmental markers in fresh p110deltaD910A/D910A BM NK cells. Percentages of positive NK cells for each marker among CD3-NK1.1+ cells are shown. Gates were set using unstained or nonspecific isotype mAb controls (not depicted). Data presented were means obtained from seven mice of each genotype. Data presented were means and standard deviations from three to five experiments.
###end p 12
###begin title 13
p110delta regulates cellularity but not NK cell commitment
###end title 13
###begin p 14
###xml 170 181 162 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 188 196 180 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 b</xref>
###xml 244 245 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 250 251 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 315 326 303 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 333 341 321 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 c</xref>
###xml 373 374 361 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 379 380 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 413 421 401 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 c</xref>
###xml 595 597 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 797 799 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 947 948 928 929 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1005 1007 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 1196 1204 1173 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 d</xref>
###xml 1252 1253 1229 1230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1258 1259 1235 1236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1450 1461 1423 1434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1468 1476 1441 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 d</xref>
###xml 1571 1572 1540 1541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1577 1578 1546 1547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1589 1597 1558 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 d</xref>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 1462 1466 <span type="species:ncbi:10090">mice</span>
To define the role of p110delta in early NK cell development, we analyzed the cell numbers. Total cellularity of both spleen and BM was significantly reduced in p110deltaD910A/D910A mice (Fig. 1 b). Concurrently, the absolute numbers of the CD3-NK1.1+ NK cell population were also reduced in the spleen of p110deltaD910A/D910A mice (Fig. 1 c). The numbers of BM-derived CD3-NK1.1+ NK cells were slightly reduced (Fig. 1 c). Recent studies have demonstrated that the process of NK cell development can be defined into five distinct stages based on the expression pattern of cell-surface markers (34). Expression of CD122, which is the beta chain of IL-2 and IL-15 receptors, marks the commitment of progenitor cells into the NK lineage in the BM. NKG2D and NK1.1 are the earliest known NK markers (35). Integrins such as CD11b (Mac-1) and CD43 (leukosialin), which can regulate lymphocyte migration and homing, are up-regulated, whereas CD51 (alphav) expression declines during the final maturation stage (34). To determine whether functional inactivation of p110delta could affect the maturation of NK cells, we analyzed the expression of developmental markers on fresh NK cells derived from BM (Fig. 1 d) and spleen (Fig. S1, available at ). Gated CD3-NK1.1+ NK cells were analyzed for the expression of CD122, NKG2D, NKG2A, CD11b, CD244, CD43, CD49b, and CD51. Expression levels of CD122, NKG2D, NKG2A, CD11b, and CD244 were unaffected in p110deltaD910A/D910A mice (Fig. 1 d). Inactivation of p110delta also did not affect the expression of CD49b, CD51, and CD43 in CD3-NK1.1+ NK cells (Fig. 1 d). Similar results were observed in IL-2-activated NK cells (Fig. S2, a and b).
###end p 14
###begin title 15
p110delta regulates the terminal maturation of Ly49C/I NK subsets
###end title 15
###begin p 16
###xml 45 46 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 250 261 246 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 268 283 264 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, a and b</xref>
###xml 427 442 419 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, a and b</xref>
###xml 557 565 549 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 c</xref>
###xml 708 716 700 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 c</xref>
###xml 799 807 791 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 d</xref>
###xml 823 834 811 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 835 839 <span type="species:ncbi:10090">mice</span>
Acquisition of distinct Ly49 receptors by CD3-NK1.1+ NK cells is an important developmental step by which the NK "repertoire" is generated. Expression of Ly49C and Ly49I were severely impaired in the fresh NK cells from the BM and spleen of p110deltaD910A/D910A mice (Fig. 2, a and b). However, expression of inhibitory Ly49A or Ly49G2 and activating Ly49D receptors was unaffected by p110delta inactivation in fresh NK cells (Fig. 2, a and b). Analyses of IL-2-activated BM NK cells further indicated the defective expression of Ly49C and Ly49I receptors (Fig. 2 c). Similar to freshly isolated NK cells, the proportion of Ly49A, Ly49D, and Ly49G2 subsets remained unaffected in IL-2-activated BM NK cells (Fig. 2 c). Comparable results were observed in spleen-derived and IL-2-activated NK cells (Fig. 2 d) from p110deltaD910A/D910A mice. Thus, a reduction in Ly49C or Ly49I did not depend on the coexpression of other Ly49 receptors, and the adverse effect of p110delta mutation only affected the maturation of Ly49C and Ly49I NK subsets.
###end p 16
###begin p 17
###xml 0 97 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Catalytic inactivation of p110&#948; results in impaired maturation of Ly49C and Ly49I NK subsets.</bold>
###xml 143 154 135 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 218 219 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 302 313 290 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 346 347 334 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 356 357 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 447 458 431 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
Catalytic inactivation of p110delta results in impaired maturation of Ly49C and Ly49I NK subsets. Expression of maturation markers on p110deltaD910A/D910A NK cells was analyzed by flow cytometry. Percentages of Ly49C/I+ NK subset are significantly reduced on both fresh BM (a) and splenic (b) p110deltaD910A/D910A NK cells. Percentages of Ly49C/I+ or Ly49I+ NK subset are significantly reduced in the IL-2-activated BM (c) or splenic (d) p110deltaD910A/D910A NK cells that were stained with anti-Ly49C/I-PE or anti-Ly49I-PE mAbs in combination with anti-Ly49G2-allophycocyanin, or anti-Ly49A-PE in combination with anti-Ly49D-FITC mAbs. Percentages of each NK subset are shown. NK cells from seven (a and b) or three (c and d) mice of each genotype were used. Data shown were obtained from three to five independent experiments.
###end p 17
###begin p 18
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 272 273 272 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 282 283 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 579 581 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 596 598 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 878 890 866 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 (a&#8211;c)</xref>
###xml 958 969 942 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1381 1389 1365 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 d</xref>
###xml 1498 1509 1478 1489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1619 1630 1595 1606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1510 1514 <span type="species:ncbi:10090">mice</span>
Reduction in the absolute NK cell numbers and in Ly49C/I needs further explanation. PI3K-mediated signaling initiates key prosurvival pathways (36). It is also important to note that only Ly49C/I receptors have the ability to recognize the self-MHC class I molecules, H2-Kb and H2-Db. Expression of these MHCs are not altered because of the inactivation of p110delta, arguing against one possible extrinsic effect during NK maturation (Fig. S3, available at ). Currently, we cannot exclude the potential possibility that p110delta-mediated signaling is required for "licensing" (37) or "arming" (38). In the absence of p110delta, either the rate of NK cell proliferation or cell survival could have been altered. To differentiate between these two possibilities, spleen-derived IL-2-activated NK cells were labeled with BrdU to analyze their proliferation. Results presented in Fig. 3 (a-c) demonstrate that the overall percentages of proliferating p110deltaD910A/D910A NK cells were significantly reduced. In particular, proliferation of Ly49C/I subsets were more severely impaired (P = 0.0096) than other Ly49 subsets. To determine the role of apoptosis in the reduction of Ly49C/I subsets, NK cells were cultured with IL-2 for 6 d, and individual subsets were analyzed with 7-aminoactinomycin D (7-AAD) and Annexin V staining. Our data indicate that among NK cells from spleen (Fig. 3 d), there was a consistent, significant but minimal increase of Annexin V-positive Ly49 subsets from p110deltaD910A/D910A mice (<10% of the total analyzed). However, no major changes were seen between BM-derived WT/WT and p110deltaD910A/D910A NK cells (Fig. S4). These results indicate that a lack of p110delta most probably affects the proliferative rate of NK cells and that the effect on their survival is minimal.
###end p 18
###begin p 19
###xml 95 106 91 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 0 112 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Defective proliferation but not increased apoptosis affects the Ly49C/I NK subsets in p110&#948;<sup>D910A/D910A</sup> mice.</bold>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
Defective proliferation but not increased apoptosis affects the Ly49C/I NK subsets in p110deltaD910A/D910A mice. IL-2-cultured splenic NK cells were pulsed with BrdU as in Materials and methods. 4 h later, NK cells were stained and analyzed for Ly49A (a), Ly49C/I (b), and Ly49G2 (c) subset proliferation. The percentages of BrdU-positive and -negative Ly49 subsets are also shown as histograms (a-c, right). Data presented are mean values from three mice of each genotype. (d) IL-2-cultured splenic NK cells were stained with Annexin V and 7-AAD for apoptosis analysis of each Ly49 NK subset. Data presented are mean values from three mice of each genotype. One representative of three independent experiments is shown.
###end p 19
###begin title 20
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 13 17 13 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 66 77 62 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
CD27HighCD11bHigh NK populations are severely reduced in p110deltaD910A/D910A mice
###end title 20
###begin p 21
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 90 94 90 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 103 106 103 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Low</sup>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 186 190 186 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 195 199 195 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 287 290 287 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Low</sup>
###xml 295 299 295 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 320 324 320 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 329 333 329 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 394 396 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 430 441 422 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 592 593 584 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 598 599 590 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 647 653 639 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 801 805 789 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 810 813 798 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Low</sup>
###xml 841 849 829 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 a</xref>
###xml 863 871 851 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 b</xref>
###xml 885 896 869 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 911 915 895 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 920 924 904 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 986 997 966 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1046 1050 1026 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 1055 1059 1035 1039 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 1125 1128 1105 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Low</sup>
###xml 1133 1137 1113 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 1193 1204 1169 1180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1304 1307 1280 1283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Low</sup>
###xml 1312 1316 1288 1292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 1327 1329 1303 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 1481 1492 1449 1460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1550 1558 1518 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 c</xref>
###xml 1625 1629 1593 1597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 1671 1682 1635 1646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1748 1749 1712 1713 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1753 1757 1717 1721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 1824 1835 1784 1795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1972 1976 1928 1932 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 1981 1985 1937 1941 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
###xml 998 1002 <span type="species:ncbi:10090">mice</span>
###xml 1493 1497 <span type="species:ncbi:10090">mice</span>
Recent studies have shown that the mature CD11b+ NK cells can be further divided into CD27High and CD27Low with distinct functional abilities (39-41). These studies demonstrate that CD27HighCD11bHigh NK cells were superior in their ability to lyse target cells compared with that of CD27LowCD11bHigh cells. Further, CD27HighCD11bHigh NK cells produced considerably higher amounts of IFN-gamma (39). Because NK cells from p110deltaD910A/D910A mice showed a specific defect in Ly49C/I expression, we extended our analyses to CD27-based NK maturation. Fresh BM and splenocytes were gated for CD3-NK1.1+ cells and analyzed for CD27 and CD11b markers. Fig. 4 shows that a lack of functional p110delta altered the ratio of CD27- and CD11b-expressing NK subsets. There was a significant reduction in the CD27HighCD11bLow NK cells in both fresh BM (Fig. 4 a) and spleen (Fig. 4 b) of p110deltaD910A/D910A mice. The CD27HighCD11bHigh NK cell numbers were also affected in the spleen of p110deltaD910A/D910A mice. More importantly, the decrease in the CD27HighCD11bHigh population was correlated with a concomitant increase in the CD27LowCD11bHigh NK subsets in both fresh BM and spleen of the p110deltaD910A/D910A NK population. Earlier studies have also indicated a skewed expression of Ly49C/I receptors in CD27LowCD11bhigh NK cells (39). Because we observed a specific reduction in the Ly49C/I subsets in the absence of functional p110delta, we analyzed the fresh NK cells from p110deltaD910A/D910A mice for CD27 and Ly49 expressions. Results presented in Fig. 4 c indicate that Ly49A, Ly49I, Ly49D, and Ly49G2 NK subsets with CD27High positivity were reduced more in p110deltaD910A/D910A NK cells than those of WT/WT. However, the reduction in the Ly49I+CD27High NK subset was more severe compared with other subsets in p110deltaD910A/D910A NK cells. Based on these results, we conclude that p110delta is needed for both Ly49C/I subset specification and proliferation, and CD27HighCD11bHigh NK maturation.
###end p 21
###begin p 22
###xml 48 52 44 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 0 64 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Catalytic inactivation of p110&#948; reduces CD27<sup>High</sup> NK subsets.</bold>
###xml 99 100 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 105 106 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 184 188 180 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 193 196 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Low</sup>
###xml 202 206 198 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 211 215 207 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 225 228 221 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Low</sup>
###xml 233 237 229 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 306 310 300 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 549 550 537 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 555 556 543 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
Catalytic inactivation of p110delta reduces CD27High NK subsets. BM- (a) or spleen- (b) derived CD3-NK1.1+ NK cells were analyzed for CD11b and CD27 expression. The percentages of CD27HighCD11bLow, CD27HighCD11bHigh, and CD27LowCD11bHigh cells were calculated. Data are means +/- SD. (c) Alteration in CD27High NK subsets correlates with the reduction in Ly49C/I NK subsets. Spleen-derived single-cell suspensions were stained with anti-NK1.1, anti-CD3epsilon, and each of the indicated anti-Ly49 or CD11b and CD27 mAbs. NK cells as specified by CD3-NK1.1+ positivity were gated and analyzed. Data shown were obtained using cells from five to seven mice of each genotype. One representative out of three independent experiments is shown.
###end p 22
###begin title 23
###xml 48 59 44 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
Cytotoxicity is marginally impaired in p110deltaD910A/D910A NK cells
###end title 23
###begin p 24
###xml 177 188 173 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 254 256 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 382 385 378 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 400 402 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 404 406 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 466 477 458 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 511 519 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 a</xref>
###xml 581 592 569 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 640 643 628 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 674 682 662 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 b</xref>
###xml 778 789 762 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 800 808 784 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 b</xref>
###xml 853 856 837 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 990 1001 970 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1132 1143 1108 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1154 1162 1130 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 b</xref>
###xml 1360 1362 1336 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 1376 1384 1352 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 b</xref>
###xml 1395 1406 1367 1378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1661 1662 1629 1630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 1664 1666 1632 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 1681 1689 1649 1657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 b</xref>
###xml 1731 1742 1695 1706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1587 1602 <span type="species:ncbi:10029">Chinese hamster</span>
A detailed analysis of the role of PI3K and its subunits in regulating "induced-self" and "missing-self" recognition is lacking. Therefore, we evaluated the ability of p110deltaD910A/D910A NK cells to mediate cytotoxicity toward several tumor targets in 51Cr-release assays. Fresh NK cells were purified from splenocytes and were tested for their ability to mediate the lysis of EL4H60 target cells (42, 43). Compared with WT/WT, the cytotoxic potential of p110deltaD910A/D910A NK cells was marginally reduced (Fig. 5 a). Similar to fresh NK cells, IL-2-activated splenic p110deltaD910A/D910A NK cells also had a reduced ability to lyse EL4H60 compared with WT/WT NK cells (Fig. 5 b). As expected, there is only a minimal lysis of EL4 by either IL-2-activated WT/WT or p110deltaD910A/D910A NK cells (Fig. 5 b). This cytotoxicity response directed to EL4H60 was primarily mediated through the NKG2D receptor, because an anti-NKG2D mAb (C7) abrogated this response in both WT/WT and p110deltaD910A/D910A NK cells (Fig. S5, available at ). Another tumor cell line, YAC-1, which naturally expresses H60, was also lysed less by p110deltaD910A/D910A NK cells (Fig. 5 b). Similar observations were made using BM-derived NK cells (unpublished data). Cells that lack or have reduced expression of self-MHC class I molecules are susceptible to NK-mediated cytotoxicity (44). As seen in Fig. 5 b, p110deltaD910A/D910A NK cells showed reduced cytotoxicity against RMA/S cells, which express lower levels of MHC class I. To test whether p110delta plays a role in Ly49D-mediated cytotoxicity, we used Chinese hamster ovary (CHO) cells that express a hamster homologue of H2-Dd (14). As shown in Fig. 5 b, spleen-derived, IL-2-activated p110deltaD910A/D910A NK cells had reduced lysis against CHO cells.
###end p 24
###begin p 25
###xml 37 48 33 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 0 94 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ex vivo&#8211; and IL-2&#8211;activated p110&#948;<sup>D910A/D910A</sup> NK cell cytotoxicity are moderately impaired.</bold>
###xml 154 156 150 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 182 185 178 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 256 258 252 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 369 372 365 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 524 535 516 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 605 606 597 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 665 666 657 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 690 691 682 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 697 700 689 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#177;</sup>
###xml 713 714 703 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 720 721 710 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 738 739 728 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 745 746 735 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 839 850 825 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 914 917 900 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
Ex vivo- and IL-2-activated p110deltaD910A/D910A NK cell cytotoxicity are moderately impaired. (a) Fresh splenic NK cells were purified and used in a 4-h 51Cr-release assay using EL4H60 target cells. (b) IL-2-activated splenic NK cells were tested against 51Cr-labeled target cells at the indicated effector/target (E/T) ratios. Cytotoxicity was tested against EL4, EL4H60, YAC-1, RMA/S, or CHO cells. Three to five mice were used for each genotype. Open and closed circles represent the mean values from WT/WT and p110deltaD910A/D910A mice, respectively. NKG2D-mediated cytotoxic potential of the Ly49C/I+ NK subset was more severely impaired compared with Ly49C/I- NK subsets. (c) Ly49C/I+Ly49G2+/-, (d) Ly49C/I-Ly49G2+, and (e) Ly49C/I-Ly49G2- NK subsets were sorted from IL-2-activated splenic NK cells derived from WT/WT and p110deltaD910A/D910A mice, rested for 12 h, and used in cytotoxicity assays with EL4H60 as target cells. Data presented are means +/- SD (a and b) or are representative (c-e) of at least three independent experiments.
###end p 25
###begin p 26
###xml 105 116 101 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 279 290 271 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 379 382 371 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 533 544 521 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 715 716 703 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 722 725 710 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#177;</sup>
###xml 735 737 721 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 778 779 764 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 785 788 771 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#177;</sup>
###xml 814 825 794 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 832 840 812 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 c</xref>
###xml 899 900 879 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 906 907 886 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 909 917 889 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 d</xref>
###xml 930 931 910 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 937 938 917 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 940 948 920 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 e</xref>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 826 830 <span type="species:ncbi:10090">mice</span>
Because the terminal maturation of Ly49C and Ly49I NK subsets was significantly impaired in the p110deltaD910A/D910A mice, we intended to analyze their functional abilities to recognize and lyse tumor cells. Toward this, the IL-2-activated splenic NK cells derived from p110deltaD910A/D910A mice were stained with anti-Ly49C/I and anti-Ly49G2 mAbs, sorted, and tested against EL4H60. Because proportions of Ly49C and Ly49I subsets are severely decreased and total numbers of spleen and BM cells are significantly reduced in p110deltaD910A/D910A mice, sorting enough Ly49C/I single-positive NK subsets is difficult. Therefore, we pooled Ly49C/I single-positive and Ly49C/I, Ly49G2 double-positive NK subsets (Ly49C/I+Ly49G2+/-) for the 51Cr-release assay. Cytotoxicity of Ly49C/I+Ly49G2+/- NK subsets from p110deltaD910A/D910A mice (Fig. 5 c) was relatively more impaired compared with sorted Ly49C/I-Ly49G2+ (Fig. 5 d) and Ly49C/I-Ly49G2- (Fig. 5 e) NK subsets. Nevertheless, these results for the first time demonstrate a preferential requirement of p110delta by Ly49C/I NK subsets for cytotoxicity.
###end p 26
###begin p 27
###xml 43 54 39 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 123 134 115 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 588 599 576 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 682 693 666 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 773 784 753 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 969 980 945 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1093 1095 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
###xml 981 985 <span type="species:ncbi:10090">mice</span>
###xml 1087 1091 <span type="species:ncbi:10090">mice</span>
Next, we evaluated the ability of p110deltaD910A/D910A mice to clear in vivo tumor growth. Toward this, WT/WT and p110deltaD910A/D910A mice were challenged with RMA and RMA/S cells. These tumor cells were labeled with CFSE or SNAF and were injected in combinations into the intraperitoneal cavity; 6 h later, peritoneal exudates were collected and analyzed for the level of tumor clearance and NK cell accumulation. Clearance of RMA/S versus RMA cells was calculated compared with the input ratio, which was normalized to one. RMA cells, which are not cleared by either WT/WT or p110deltaD910A/D910A mice, acted as an internal control. Our results show that both WT/WT and p110deltaD910A/D910A mice did not clear RMA cells. Compared with WT/WT, the ability of the p110deltaD910A/D910A mice to clear the RMA/S cells was marginally impaired (Fig. S6, a and b, available at ). Comparable numbers of NK cells accumulated in the peritoneal cavity of both WT/WT and p110deltaD910A/D910A mice (Fig. S6, c and d). These results confirm our in vitro observations and the earlier reports on these mice (45).
###end p 27
###begin title 28
###xml 54 65 50 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
Cytokine/chemokine generation is impaired in p110deltaD910A/D910A NK cells
###end title 28
###begin p 29
###xml 222 224 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 251 252 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 257 258 246 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 313 314 302 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 319 320 308 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 512 523 497 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 603 611 588 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 a</xref>
###xml 868 876 845 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 b</xref>
###xml 1024 1035 993 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1182 1193 1140 1151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1235 1243 1193 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 b</xref>
###xml 1338 1349 1292 1303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1461 1472 1411 1422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1747 1748 1689 1690 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1773 1784 1711 1722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1859 1867 1797 1805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 a</xref>
###xml 2153 2164 2079 2090 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 2247 2255 2169 2177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 b</xref>
###xml 2640 2648 2554 2562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 a</xref>
###xml 2763 2774 2669 2680 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 3146 3157 3048 3059 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 3243 3251 3145 3153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 b</xref>
###xml 3387 3398 3285 3296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 2165 2169 <span type="species:ncbi:10090">mice</span>
NK cells can generate inflammatory cytokines and chemokines such as IFN-gamma, GM-CSF, macrophage inflammatory protein (MIP) 1alpha, MIP-1beta, and regulated upon activation, normal T cell expressed and secreted (RANTES) (46). Therefore, we tested CD3-NK1.1+ NK cells for cytokine generation. Freshly purified CD3-NK1.1+ NK cells from WT/WT spleens generated an optimal amount of cytokines and chemokines when activated by plate-bound anti-NKG2D, anti-Ly49D, and anti-NK1.1 mAbs. However, NK cells from p110deltaD910A/D910A mice were significantly impaired in generating these cytokines and chemokines (Fig. 6 a). Thus, the ex vivo-purified NK cells that use NKG2D-DAP10 complexes for signaling depend on p110delta to generate cytokine response. Next, we tested the role of p110delta in cytokine and chemokine generation by IL-2-activated splenic NK cells. As seen in Fig. 6 b, WT/WT NK cells produced a large amount of IFN-gamma or GM-CSF when stimulated with anti-NKG2D, anti-Ly49D, and anti-NK1.1 mAbs. However, p110deltaD910A/D910A NK cells were severely impaired to produce these cytokines. Further, generation of the chemokines MIP1-alpha, MIP1-beta, and RANTES from p110deltaD910A/D910A NK cells was also significantly reduced (Fig. 6 b). Similar reductions in the cytokines and chemokines were observed in the BM-derived p110deltaD910A/D910A NK cells (Fig. S7, available at ). This substantial reduction could be caused by the inability of the p110deltaD910A/D910A NK cells to produce cytokines or simply by a defect in cytokine secretion. To distinguish between these two possibilities, IFN-gamma production in response to anti-NKG2D mAb was measured by intracellular staining. The percentage of IFN-gamma-positive cells among gated NK1.1+ populations in p110deltaD910A/D910A NK cells was significantly lower compared with WT/WT NK cells (P = 0.017; Fig. 7 a) Inactivation of p110delta reduced the number and functions of NK cells, particularly, the Ly49C/I subsets. Therefore, to determine the cytokine defects in individual Ly49 subsets, we analyzed the levels of intracellular IFN-gamma in each one of them. All of the subsets from p110deltaD910A/D910A mice generated a significantly less amount of intracellular IFN-gamma (P < 0.007; Fig. 7 b), and we did not see any preferential reduction in Ly49C/I subsets. This indicates that although p110delta regulates both of the effector functions, it is critically required for cytokine generation. To further investigate whether the defect is at the transcriptional level, we quantified the amounts of IFN-gamma-encoding mRNA before and after plate-bound anti-NKG2D mAb activation. Fig. 8 a demonstrates a significantly lower copy number of IFN-gamma-encoding mRNA in both BM- and spleen-derived p110deltaD910A/D910A NK cells, indicating a defect at the transcriptional level. To determine whether this is generalized hyporesponsiveness or an exclusive defect associated with YINM- and ITAM-containing activation receptors, we stimulated the NK cells with IL-12, IL-18, or both in the presence of a suboptimal concentration of anti-NKG2D mAb (A10). Interestingly, both WT/WT and p110deltaD910A/D910A-derived NK cells responded equally well to distinct combinations of this activation (Fig. 8 b). Similar results were obtained using IL-12, IL-18, or both without anti-NKG2D mAb (unpublished data). This demonstrates that p110deltaD910A/D910A NK cells are fully capable of responding through their cytokine receptors.
###end p 29
###begin p 30
###xml 48 59 44 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 0 126 0 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ability of ex vivo&#8211; and IL-2&#8211;activated p110&#948;<sup>D910A/D910A</sup> NK cells to generate cytokines or chemokines is severely impaired.</bold>
###xml 133 134 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 163 164 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 169 170 165 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 389 390 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
Ability of ex vivo- and IL-2-activated p110deltaD910A/D910A NK cells to generate cytokines or chemokines is severely impaired. (a) 105 freshly purified splenic CD3-NK1.1+ NK cells per well were activated with plate-bound anti-NKG2D (A10), anti-Ly49D (4D11), or anti-NK1.1 (PK136) mAbs, and the supernatants were tested for the indicated cytokines and chemokines in Multiplex assays. (b) 105 IL-2-activated splenic NK cells per well were activated with plate-bound anti-NKG2D (A10), anti-Ly49D (4D11), or anti-NK1.1 (PK136) mAbs, and the resulting supernatants were used in Multiplex assays. Data presented are mean values +/- SD from six mice of each genotype from two independent experiments.
###end p 30
###begin p 31
###xml 33 44 25 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 0 89 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IFN-&#947; generation by p110&#948;<sup>D910A/D910A</sup> NK cells were defective in all Ly49 subsets.</bold>
###xml 177 188 161 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 441 442 421 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 447 448 427 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 560 571 532 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 596 597 568 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 602 603 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
IFN-gamma generation by p110deltaD910A/D910A NK cells were defective in all Ly49 subsets. (a) Levels of intracellular IFN-gamma positivity are significantly reduced in p110deltaD910A/D910A NK cells. IL-2-activated splenic NK cells were stimulated with plate-bound anti-NKG2D (A10) mAb for 8 h, combined with Brefeldin A, and incubated for another 4 h. Activated NK cells stained for intracellular IFN-gamma. Cells shown are gated for the CD3-NK1.1+ NK population. (b) Levels of intracellular IFN-gamma positivity in different Ly49 subsets from WT and p110deltaD910A/D910A mice. Percentages of CD3-NK1.1+ NK cells that were positive for intracellular IFN-gamma are shown with Ly49 markers. Data presented are representative of three independent experiments.
###end p 31
###begin p 32
###xml 147 158 143 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 0 168 0 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Defect in cytokine production occurs at the transcriptional level, and IL-12/IL-18&#8211;mediated generation of cytokine/chemokine is intact in p110&#948;<sup>D910A/D910A</sup> NK cells.</bold>
###xml 173 182 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN-&#947;</italic>
###xml 229 240 217 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 332 341 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN-&#947;</italic>
Defect in cytokine production occurs at the transcriptional level, and IL-12/IL-18-mediated generation of cytokine/chemokine is intact in p110deltaD910A/D910A NK cells. (a) IFN-gamma-encoding mRNA levels were reduced in p110deltaD910A/D910A NK cells. NK cells were stimulated with anti-NKG2D mAb for 6 h, and mRNA was extracted and IFN-gamma-encoding transcripts were quantified. (b) NK cell cytokine and chemokine production upon stimulation with a suboptimal concentration of anti-NKG2D mAbs in the presence or absence of IL-12, IL-18, or both. Data presented are means +/- SD and are representative of three independent experiments.
###end p 32
###begin title 33
NK-mediated cytokine production requires p110delta during antiinfluenza response
###end title 33
###begin p 34
###xml 337 345 333 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 a</xref>
###xml 583 585 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 740 751 728 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1034 1045 1018 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1056 1064 1040 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 b</xref>
###xml 1152 1160 1136 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 c</xref>
###xml 1208 1219 1188 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1352 1354 1332 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 1472 1480 1452 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 d</xref>
###xml 1587 1598 1559 1570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
###xml 384 389 <span type="species:ncbi:10090">mouse</span>
###xml 398 403 <span type="species:ncbi:9606">human</span>
Influenza virus primarily infects lung epithelial cells that can lead to lung pathogenesis. Hence, in this study, we used mouse lung epithelial cells (LA4) to characterize the role of p110delta in NK cytotoxicity and cytokine generation during influenza virus infection. We detected the cell-surface expression of viral HA on LA4 cells (Fig. 9 a) after they were infected with PR8, a mouse-adapted human influenza virus. A previous study showed that HA functions as a viral ligand for NCR1, and its interaction with NCR1 can initiate NK cytolysis against PR8-infected 1106mel cells (21). To determine the role of p110delta in regulating the NCR1-mediated NK cell recognition of PR8-infected LA4 cells, we first compared the WT and p110deltaD910A/D910A NK cytotoxicity. Co-incubation of WT/WT NK cells with uninfected LA4 cells led to a basal level of cytotoxicity. PR8 infection of LA4 cells moderately increased the cytotoxic potentials of WT/WT NK cells. However, such an increase in the cytotoxicity was not observed with p110deltaD910A/D910A NK cells (Fig. 9 b). Further, direct observations of the lysis of PR8-infected LA4 in NK/LA4 co-cultures (Fig. 9 c) validated the reduced ability of the p110deltaD910A/D910A NK cells to mediate killing of virally infected cells. Because NK cells can generate inflammatory cytokines during viral infection (46), we quantified these soluble mediators in the supernatants of PR8-infected LA4/NK co-cultures. Results presented in Fig. 9 d demonstrate that although the WT/WT NK cells could produce ample levels of IFN-gamma and GM-CSF, p110deltaD910A/D910A NK cells generated significantly lower levels of these two cytokines. Collectively, these results for the first time demonstrate that p110delta plays a crucial role in the NK cell-mediated cytokine generation during antiinfluenza viral responses.
###end p 34
###begin p 35
###xml 23 34 19 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 0 145 0 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink">NK cells from p110&#948;<sup>D910A/D910A</sup> mice have a decreased ability to mediate cytotoxicity and produce cytokines against influenza virus infection.</bold>
###xml 347 358 339 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 448 450 440 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 553 564 541 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 598 609 582 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 967 978 946 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
NK cells from p110deltaD910A/D910A mice have a decreased ability to mediate cytotoxicity and produce cytokines against influenza virus infection. (a) LA4 cells were infected with PR8 at an MOI of 0.05. 24 h after infection, expression of HA was quantified using anti-HA mAb by flow cytometry. (b) Recognition of PR8-infected LA4 cells by p110deltaD910A/D910A NK cells is impaired. LA4 was infected with PR8 at an MOI of 0.05 for 24 h, labeled with 51Cr, and used for cytotoxicity assays. Data presented are the mean values from three WT/WT and p110deltaD910A/D910A mice, respectively. (c) p110deltaD910A/D910A NK cells have severely impaired ability to lyse infected LA4 cells, as shown by direct observation of cytolysis. LA4 cells were infected with PR8 at an MOI of 0.05 for 1 h, and NK cells were added and co-cultured for 8 h. Lysis of the infected LA4 monolayer was observed under light microscopy and recorded with a mounted camera. Bars, 12 mum. (d) p110deltaD910A/D910A NK cells generate significantly lower levels of cytokines when co-cultured with PR8-infected LA4 cells. Generation of IFN-gamma and GM-CSF was quantified in the supernatants of PR8-infected LA4/NK cell co-cultures collected at 24 h after infection. Data presented were either one representative or means, and mean values of three to five experiments.
###end p 35
###begin title 36
JNK1/2 regulates cytokine generation downstream of p110delta
###end title 36
###begin p 37
###xml 294 296 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 297 299 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 408 410 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 412 414 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 735 746 723 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 826 837 810 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 848 857 832 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 a</xref>
###xml 943 954 923 934 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 965 974 945 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 a</xref>
###xml 1251 1254 1227 1230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 1295 1306 1267 1278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1380 1391 1348 1359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1453 1462 1421 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 b</xref>
###xml 1600 1609 1568 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 b</xref>
###xml 1773 1782 1741 1750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 c</xref>
###xml 1867 1878 1831 1842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 2243 2245 2207 2209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 2611 2622 2571 2582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 268 273 <span type="species:ncbi:10090">mouse</span>
###xml 278 283 <span type="species:ncbi:9606">human</span>
What are the downstream targets of p110delta that regulate the cytotoxicity and cytokine gene transcriptions? Earlier studies have shown that activation of mitogen-activated protein kinases (MAPKs) are required for cytotoxic granule release and cytokine generation in mouse and human NK cells (47-50). Also, the proposed involvement of p38 and JNK1/2 in regulating NK cell effector functions is contentious (49, 50). To identify the target molecules downstream of p110delta, NK cells were activated with plate-bound NKG2D mAb, and their lysates were analyzed for the activation status of multiple MAPKs. Phosphorylation levels of extracellular signal-regulated kinase (ERK) 1/2 were comparable between the activated WT/WT and p110deltaD910A/D910A NK cells. p38 phosphorylation is slightly but consistently reduced in p110deltaD910A/D910A NK cells (Fig. 10 a). However, the level of JNK1/2 phosphorylation was significantly reduced in p110deltaD910A/D910A NK cells (Fig. 10 a). These results indicate that JNK1/2 are major target molecules downstream of p110delta in NK cells. We confirmed the role of JNK1/2 using a specific pharmacological inhibitor of JNK activation, SP600125. Use of this inhibitor significantly reduced NKG2D-mediated lysis of EL4H60 target cells by both WT/WT and p110deltaD910A/D910A NK cells in a dose-dependent manner. However, the inhibition on p110deltaD910A/D910A NK cells was significantly less than that on WT/WT NK cells (Fig. 10 b). Blocking the function of p38 with its inhibitor, SB202190, had no significant effect on NKG2D-mediated lysis of the same target cells (Fig. 10 b). To determine their role in cytokine generation, we blocked JNK1/2 and p38 and assayed the ability of NK cells to respond to anti-NKG2D mAb-mediated stimulation. Fig. 10 c shows that inhibiting JNK function abolished the ability of both WT/WT and p110deltaD910A/D910A NK cells to generate cytokines and chemokines in a dose-dependent manner. Conversely, p38 inhibitor only weakly blocked the cytokine generation, further confirming the crucial role of JNK1/2 in cytokine gene transcription. To avoid the nonspecific inhibition on other kinases, we tested, selected, and used two optimal concentrations of JNK1/2 and p38 inhibitors (51). Further, cells treated under these concentrations were tested for their viability using Annexin V and 7-AAD staining, which excluded cell death as the reason for our observations (unpublished data). Based on these results, we conclude that impairment in the JNK1/2 activation is a probable cause for the defect in cytotoxicity and cytokine generation in p110deltaD910A/D910A NK cells.
###end p 37
###begin p 38
###xml 0 78 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">JNK1/2 regulates cytotoxicity and cytokine generation downstream of p110&#948;.</bold>
###xml 351 354 347 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
JNK1/2 regulates cytotoxicity and cytokine generation downstream of p110delta. (a) IL-2-cultured NK cells were stimulated with plate-bound anti-NKG2D mAb for the indicated times. Phosphorylation of ERK1/2, JNK1/2, and p38 was detected by Western blotting. One representative experiment out of three is shown. (b) Inhibition of cytotoxicity against EL4H60 by p38 inhibitor(SB 202190) or JNK1/2 inhibitor (SP600125). (c) Inhibition of cytokine/chemokine generation upon stimulation with plate-bound anti-NKG2D mAb by p38 inhibitor (SB 202190) or JNK1/2 inhibitor (SP600125). Data presented in b and c were means +/- SD obtained from three mice of each genotype. Data shown were obtained from three to five independent experiments.
###end p 38
###begin title 39
DISCUSSION
###end title 39
###begin p 40
###xml 214 216 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 218 220 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 222 224 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 242 253 234 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
In this study, we present genetic evidence that unmasks the critical functions of PI3K-p110delta in NK cells. The important role of PI3K in T and B cell development and function has been extensively characterized (28, 29, 32). Using p110deltaD910A/D910A mice, we demonstrate that p110delta plays a crucial role in NK cell terminal maturation and cytokine/chemokine generation.
###end p 40
###begin p 41
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p85</italic>
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p110</italic>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">53</xref>
###xml 340 342 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 344 346 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 433 435 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 647 649 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 906 908 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 1042 1044 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 1248 1250 1179 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 1414 1416 1338 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 1505 1516 1425 1436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1745 1747 1657 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 2021 2032 1921 1932 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 2039 2041 1939 1941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 2147 2158 2037 2048 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 2283 2285 2173 2175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 2407 2409 2297 2299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
###xml 952 956 <span type="species:ncbi:10090">mice</span>
###xml 1081 1085 <span type="species:ncbi:10090">mice</span>
###xml 1517 1521 <span type="species:ncbi:10090">mice</span>
###xml 2033 2037 <span type="species:ncbi:10090">mice</span>
###xml 2512 2517 <span type="species:ncbi:10090">mouse</span>
In recent years, multiple p85 and p110 gene KO mice have been generated (28, 29, 33, 52, 53). Interestingly, in these KO mice, altering the expression of one PI3K subunit has affected the expression of others. Cells from p85alpha KO mice contained increased levels of p85beta and decreased expression of p110alpha, p110beta, and p110delta (28, 29). In contrast, the levels of p85alpha expression were augmented in p110alpha KO mice (33). Some of these mice have been recently used to characterize the development and functions of NK cells. Tassi et al. shows a significant reduction of p85alpha subunit in NK cells derived from p110delta KO mice (54). Also, NK cells from these mice have increased expression of p110beta and p110gamma subunits, although the p110alpha expression level was not changed. Recently, another independently generated p110delta KO mice were used by Kim et al. in a NK cell study (55), and an earlier characterization of these mice showed decreased expression of p85alpha, p55alpha, and p50alpha subunits in B cells (52). Therefore, in this study, we used mice with a point mutation that completely inactivated the catalytic function of p110delta subunit without altering the normal expression levels of p110delta protein (32). More importantly, this strategy did not result in any compensatory change in the expression levels of total p85, p110alpha, and p110beta subunits in thymocytes (32). In the present study, we show that both BM- and spleen-derived NK cells from p110deltaD910A/D910A mice did not have any alteration in the levels of either p110delta or other p110 subunits. Further, there were no changes in the levels of total p85 or p85alpha subunits. These results are in line with our earlier observations (32). However, one of the major concerns in introducing a single amino acid change in p110delta protein is its possible dominant negative effect. Our earlier findings demonstrated a differential sensitivity of distinct receptor systems after p110delta inactivation in p110deltaD910A/D910A mice (56). For example, PI3K signaling via c-kit and FcepsilonRI receptors was almost fully abolished in p110deltaD910A/D910A mast cells; this is in contrast to PI3K (Akt/protein kinase B) signaling induced by IL-3, which was only partially blocked (56). The remaining PI3K signaling downstream of the IL-3 receptor could be fully blocked by broad-spectrum PI3K inhibitors (56), indicating that kinase-dead p110delta does not exert a dominant-negative function. Thus, a knock-in mouse with a point mutation in p110delta that abolishes its kinase function but not its protein expression provides an exclusive system to delineate the precise functions of PI3K in NK cells.
###end p 41
###begin p 42
###xml 15 26 11 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 189 191 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">57</xref>
###xml 324 326 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 475 477 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 516 527 508 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 795 796 779 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 803 805 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">59</xref>
###xml 806 808 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 1066 1068 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 1170 1172 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 1174 1176 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 1227 1238 1199 1210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Using p110deltaD910A/D910A mice, we first determined the development and maturation of NK cells. Common lymphoid progenitors that give rise to T, B, and NK cells have been found in the BM (57). Committed NK precursors (NKPs), which exclusively mature into NK cells, have been identified in the fetal thymus and in adult BM (58). This earliest developmental stage of NKPs is defined by the expression of CD122. Thus, the expression of CD122 uniquely marks the committed NKPs (35). The expression of CD122 in p110deltaD910A/D910A NK cells is comparable to that of WT, indicating that the catalytic activity of p110delta is dispensable for the early NK cell development. In addition, earlier studies from us and others showed that a lack of phospholipase C gamma2 did not alter the numbers of CD122+ NKPs (59-61). Thus, it appears that neither p110delta nor phospholipase C gamma2 are needed for the commitment of early progenitors into NK lineage. In the second developmental stage, NKPs acquire NK1.1, NKG2D, and CD94/NKG2A/C/E in a sequential developmental process (34). The start of the expression of integrins such as CD49b and CD51 is also part of this second stage (34, 58). Normal expressions of these markers by p110deltaD910A/D910A NK cells in the BM and spleen demonstrate that NK maturation is not hindered at this stage.
###end p 42
###begin p 43
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 374 385 370 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 659 661 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 1018 1020 974 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 1036 1047 988 999 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1299 1300 1247 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1345 1349 1293 1297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 1358 1361 1306 1309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Low</sup>
###xml 1363 1365 1311 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 1401 1405 1349 1353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 1549 1552 1493 1496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Low</sup>
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 913 917 <span type="species:ncbi:10090">mice</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
###xml 1012 1016 <span type="species:ncbi:10090">mice</span>
###xml 1048 1052 <span type="species:ncbi:10090">mice</span>
###xml 1111 1115 <span type="species:ncbi:10090">mice</span>
###xml 1188 1192 <span type="species:ncbi:10090">mice</span>
Mature mouse NK cells are defined by the expression of one or more Ly49 receptors. Terminal maturation of NK cells is initiated by a decrease in the expression of CD51, active proliferation, and a concomitant increase in the levels of both CD11b and CD43 (34). At this stage, the "immature" NKPs start acquiring different Ly49s (58). Analyses of Ly49 expression on p110deltaD910A/D910A NK cells indicated an exclusive reduction in Ly49C and Ly49I subsets. Other NK subsets, such as Ly49A, Ly49G2, and Ly49D were normal. Recently, Tassi et al. has used p110gamma, p110delta, or p110gamma/delta double KO mice to determine the NK cell development and function (54). These studies showed reductions in Ly49A and Ly49C/I subsets in p110gamma and p110gamma/p110delta double KO mice; however, no changes were observed in Ly49C/I NK subsets in p110delta KO mice. Conversely, Kim et al., using independently generated KO mice, demonstrated small reductions in the Ly49C/I in p110gamma KO mice and Ly49G2 in p110delta KO mice (55). The p110deltaD910A/D910A mice used in the present study and one of the two p110delta KO mice are of the C57BL/6 background. This suggests that strain differences in mice did not account for the observed variations in the results. Recent studies indicated that the mature CD11b+ NK cells can be further subdivided into CD27High and CD27Low (39). This study demonstrated that CD27High NK cells were superior in their ability to lyse target cells and generated considerably higher amounts of IFN-gamma compared with those of CD27Low cells.
###end p 43
###begin p 44
###xml 56 67 52 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 143 147 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTEN</italic>
###xml 280 282 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 359 363 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTEN</italic>
###xml 405 409 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTEN</italic>
###xml 439 450 431 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 457 459 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
Reduction in the Ly49C and Ly49I NK subsets in p110deltaD910A/D910A mice needs further evaluation. Gene deletion of another lipid phosphatase, PTEN, whose major substrate is phosphatidylinositol (3,4,5)-triphosphate, leads to an increased Ly49C and Ly49I expression in NKT cells (62). Interestingly, this abnormal increase of Ly49C or Ly49I in NKT cells from PTEN KO mice was reversed by backcrossing the PTEN-deficient mice with p110deltaD910A/D910A mice (62). Collectively, our findings in the reduction of Ly49C and Ly49I expression predict a key role for p110delta in the dynamic interaction between PI3K, phosphatidylinositol (3,4,5)-triphosphate, lipid phosphatases, and inhibitory Ly49 receptors.
###end p 44
###begin p 45
###xml 366 370 358 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 394 405 382 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 508 510 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 726 727 714 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 729 731 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 733 735 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib63">63</xref>
###xml 852 863 836 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 935 946 915 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1036 1038 1012 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 1182 1186 1154 1158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 1191 1195 1163 1167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 1264 1266 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 1308 1312 1276 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">High</sup>
###xml 1334 1345 1298 1309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1551 1553 1511 1513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib64">64</xref>
###xml 1910 1921 1855 1866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1969 1971 1910 1912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 2142 2153 2075 2086 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 2283 2294 2212 2223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 2391 2393 2320 2322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">65</xref>
###xml 2395 2397 2324 2326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib66">66</xref>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 1346 1350 <span type="species:ncbi:10090">mice</span>
NK cells can kill tumor cells without prior sensitization. To study the role of p110delta in lytic signaling, we used different tumor cells representing self, induced-self, and missing-self. Lack of p110delta moderately affected the antitumor responses against these target cells. This marginal impairment in cytotoxicity could be caused by the reduction in the CD27High NK subsets in p110deltaD910A/D910A mice, because this subset has been demonstrated to play a dominant role in cytotoxic granule release (39). NK cells generate inflammatory cytokines and chemokines as part of innate immunity. Previous studies demonstrated a lack of DAP12 or Syk/ZAP70 but not DAP10, severely impairing NKG2D-mediated cytokine production (7, 11, 63). In contrast, a significant reduction in cytokine generation mediated via NKG2D and Ly49D was observed in p110deltaD910A/D910A NK cells. Further, similar reductions were also observed when p110deltaD910A/D910A NK cells were activated via the NK1.1 receptor that uses FcRgamma to mediate its signal (24). These results suggest that p110delta plays a pivotal role in the cytokine generation by NK cells. Earlier studies have demonstrated that CD27HighCD11bHigh NK cells generated IFN-gamma in response to NKG2D-mediated stimuli (39). Thus, a significant decline in the CD27High NK cells in p110deltaD910A/D910A mice provides additional cellular explanations for the reduction in cytokine generation. The proinflammatory cytokines IL-12 and IL-18, derived from monocytes, can induce IFN-gamma generation in NK cells (64). In combinations, IL-12 and IL-18 can mediate signaling events that are distinct from those of YINM- or ITAM-containing receptor-mediated activations. Stimulation with IL-12 and IL-18, along with a suboptimal concentration of anti-NKG2D mAb, resulted in comparable levels of IFN-gamma, GM-CSF, MIP-1alpha, MIP-1beta, and RANTES between WT/WT and p110deltaD910A/D910A NK cells. Compared with p110delta KO NK cells (55), we did not observe any increased production of IFN-gamma upon IL-12 and IL-18 stimulation. We conclude that ITAM-independent pathways are fully operational in p110deltaD910A/D910A NK cells. An explanation for this observation comes from the comparable levels of p38 phosphorylation between WT/WT and p110deltaD910A/D910A NK cells, which is crucial for the generation of cytokines downstream of IL-12/IL-18 receptors (65, 66).
###end p 45
###begin p 46
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib67">67</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib68">68</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib67">67</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib69">69</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib70">70</xref>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib70">70</xref>
###xml 1257 1259 1253 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 1369 1371 1365 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib71">71</xref>
###xml 1512 1514 1504 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib72">72</xref>
###xml 1087 1092 <span type="species:ncbi:9606">human</span>
###xml 1496 1501 <span type="species:ncbi:9606">human</span>
MAPKs are potential downstream targets for multiple activation receptors, including NKG2D (67). MAPKs are serine-threonine kinases with a T-X-Y motif in their cytoplasmic domain, and they regulate multiple immune cell effector functions (68). The MAPK family includes ERK1/2, JNK1/2, and p38. The regulatory roles of these MAPKs in NK functions are emerging (47-50, 67, 69). ERK1/2 can be activated by multiple mitogenic stimuli; however, JNK1/2 and p38 are activated by stress-inducing agents or proinflammatory cytokines. Earlier studies using T cells have provided evidence for the role of PI3K in JNK activation (70). In T cells, full activation of the MAPKs that phosphorylate the Jun activation domain of JNK1 and JNK2 needs combined stimulation through TCR and CD28 together; alone, each stimulus resulted in little or no effect (70). Our data indicate that JNK1/2 are critical downstream effectors of P110delta, and that they could regulate cytokine gene transcription and cytotoxic granule release. These findings are in line with the recent observations in an NKG2D-expressing human NKL cell line, where inhibition of JNK activity resulted in the impaired movement of microtubule organizing center, granzyme B, and paxillin to the immune synapse (49). Several transcription factors as substrates have been described for JNK1/2, including activator protein 1 (71). Evidence for this is provided by the activator protein 1-dependent cytokine gene transcription in FcgammaRIIIA-stimulated human NK cells (72). In conclusion, our current observations establish a strong basis to further explore PI3K-mediated novel NK cell cytokine generation pathways.
###end p 46
###begin p 47
###xml 287 289 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 383 385 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib73">73</xref>
###xml 623 634 615 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 802 813 786 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 1063 1065 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib74">74</xref>
###xml 370 375 <span type="species:ncbi:10090">mouse</span>
###xml 533 538 <span type="species:ncbi:10090">Mouse</span>
NK cells can clear an intracellular infection either by direct killing of the infected cells or through the release of cytokines, e.g., IFN-gamma. It has been demonstrated that NK cells can recognize and kill influenza virus-infected cells through the interaction of NCR1 with viral HA (21). Further, functional loss of NCR1 caused lethal influenza virus infection in a mouse model (73). However, the signaling pathway governing NCR1-mediated activation has not been investigated. Influenza virus primarily target respiratory cells. Mouse lung epithelial cells (LA4) can be infected with PR8 and express viral HA. p110deltaD910A/D910A NK cells showed reduced lysis against PR8-infected cells, which indicates the involvement of p110delta in NCR1-mediated cytotoxicity. Most significantly, the p110deltaD910A/D910A NK cells were impaired in their ability to produce IFN-gamma and GM-CSF upon recognition of PR8-infected LA4, confirming the importance of p110delta in antiviral immunity. Replication of high pathogenic influenza infection usually peaks within 5 d (74). Controlling flu infection during this short time window currently relies on antiflu drugs and vaccines, which usually are not effective for virulent influenza virus. Our results suggest an alternative approach to control emerging pandemic influenza infection by boosting the NK cell effector functions through potential drugs specifically targeted to signaling molecules.
###end p 47
###begin title 48
MATERIALS AND METHODS
###end title 48
###begin title 49
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and cell lines.
###end title 49
###begin p 50
###xml 28 39 24 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 71 73 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 90 101 82 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 480 483 472 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 559 561 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 666 671 <span type="species:ncbi:10090">mouse</span>
Generation of PI3K-p110deltaD910A/D910A mice was previously described (30). PI3K-p110deltaD910A/D910A mice used in the present study were backcrossed to C57BL/6 for N12/N13 generations. The mutant and C57BL/6 (WT/WT) mice were maintained in pathogen-free conditions at the Biological Resource Center (BRC) of the Medical College of Wisconsin (MCW). All of the animal protocols used were approved by the Institutional Animal Care and Use Committee, BRC, MCW. Target cells (EL4, EL4H60, RMA/S, and YAC-1) and their culture conditions were previously described (35). CHO cells were cultured similarly to other target cells. Madin-Darby canine kidney (MDCK) cells and a mouse lung epithelial cell line (LA4) were purchased from the American Type Culture Collection and were cultured in RPMI 1640 medium with 10% or 15% FBS, respectively.
###end p 50
###begin title 51
Virus and viral infections.
###end title 51
###begin p 52
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 14 19 <span type="species:ncbi:9606">human</span>
Mouse-adapted human influenza virus A/PR8 (H1N1) was obtained from T. Moran (Mount Sinai School of Medicine, New York, NY). Influenza virus stocks were propagated in MDCK cells, and titers were determined by a plaque-forming assay.
###end p 52
###begin title 53
NK cell preparation.
###end title 53
###begin p 54
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 388 389 388 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
NK cells were purified as previously described (35). In brief, single-cell suspensions from spleen and BM were passed through nylon wool columns to deplete adherent populations consisting of B cells and macrophages. Nylon wool-nonadherent cells were cultured with 1,000 U/ml of IL-2 (NCI BRB Preclinical Repository). Purity of the NK cultures was checked, and preparations with >90% NK1.1+ cells were used. Alternatively, for ex vivo assays, NK cells were purified with DX5 mAb (eBioscience) by magnetic sorting according to manufacture's protocol. Purify of NK cells was usually approximately80%.
###end p 54
###begin title 55
Co-culture assays.
###end title 55
###begin p 56
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
2.5 x 105 LA4 cells per well were seeded in 24-well tissue culture plates overnight. Cells were washed twice and inoculated with PR8 at a multiplicity of infection (MOI) of 0.05. After a 1-h incubation at 37degreesC, the inoculum was removed and LA4 cells were washed twice, followed by the addition of IL-2-activated splenic NK cells at the ratios indicated in the figures. Supernatants were collected at the times indicated in the figures for cytokine quantification.
###end p 56
###begin title 57
Flow cytometry.
###end title 57
###begin p 58
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib75">75</xref>
###xml 450 451 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 460 461 454 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 722 733 712 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 922 925 912 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 440 445 <span type="species:ncbi:10090">mouse</span>
###xml 734 738 <span type="species:ncbi:10090">mice</span>
Cell preparations were stained with fluorescent-labeled mAbs, as previously described (75). mAbs for NK1.1 (PK136), CD3epsilon (145-2C11), NKG2D (A10), NKG2A (16a11), CD43 (1B11), CD49b (DX5), CD51 (RMV-7), CD69 (H1.2F3), CD122 (5H4), CD11b (M1/70), CD27 (LG.7F9), and Ly49I (YLI-90) were obtained from eBioscience. mAbs for CD244 (2B4), Ly49A (A1), Ly49D (4E5), Ly49C/I (5E6), and Ly49G2 (4D11) were obtained from BD Biosciences. mAbs for mouse H-2Kb and H-2Db were obtained from Invitrogen. Antibody for influenza HA (IVC102) was obtained from GeneTex, Inc. A standard flow cytometry analysis was performed using an LSR II with FACSDiva software (Becton Dickinson). IL-2-activated splenic NK cells derived from p110deltaD910A/D910A mice were also stained with Ly49C/I (5E6) and Ly49G2 (4D11) mAbs and subjected to cell sorting using a FACSAria (Becton Dickinson). Cytotoxicity of sorted NK subsets was tested against EL4H60 (see the following section).
###end p 58
###begin title 59
Cytotoxicity assays.
###end title 59
###begin p 60
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 91 94 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 319 322 319 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 456 458 456 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 724 725 722 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 804 809 <span type="species:ncbi:10090">mouse</span>
NK-mediated cytotoxicity was quantified using 51Cr-labeled target cells, including EL4, EL4H60, RMA/S, YAC-1, CHO, and PR8-infected and noninfected LA4 cells at varied effector/target ratios. Anti-NKG2D mAb C7 (eBioscience) were used at the concentrations indicated in the figures to block the recognition of H60 on EL4H60 through the NKG2D receptor. The percentage of specific lysis was calculated using amounts of absolute, spontaneous, and experimental 51Cr release from target cells. For the in vivo tumor clearance assay, RMA and RMA/S cells were labeled with 0.1 muM CFSE and 0.2 muM SNAF (Invitrogen), respectively, for 10 min and were quenched with 10% FBS 1640 medium. Cells were mixed at a concentration of 10 x 106 cells/ml of each in PBS, and 400 mul was injected intraperitoneally into each mouse. Peritoneal exudate was collected 6 h later, and the fluorescence of single-cell suspensions was analyzed by flow cytometry. The ratio of RMA/S to RMA cells was calculated. NK cells in the cell suspensions were analyzed by staining with anti-CD3 and anti-NK1.1 mAbs. A dye swap was also performed.
###end p 60
###begin title 61
NK cell proliferation.
###end title 61
###begin p 62
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Splenic NK cells were cultured for 6 d, harvested, seeded into a 6-well plate (2 x 106 cells/well), and incubated for 2 h. BrdU was then added to a final concentration of 10 muM, and cells were further incubated for 4 h, after which cells were stained with anti-CD3, -NK1.1, -Ly49A, -Ly49C/I, and -Ly49G2 mAbs for 30 min on ice, washed, and fixed with 1% paraformaldehyde-0.01% Tween-20 in PBS at 4degreesC for 20 min. Cells were washed and resuspended in permeabilization buffer containing 50 Kunitz DNase I/ml and incubated for 30 min at 37degreesC. After the wash, cells were finally stained with anti-BrdU-FITC (BD Biosciences). For apoptosis analysis, 6-d IL-2-activated NK cells were stained with FITC-conjugated mAbs for Ly49A, Ly49D, Ly49C/I, and Ly49G2; washed; and stained with 7-AAD and Annexin V-PE (BD Biosciences), according to manufacturer's protocol.
###end p 62
###begin title 63
Western blotting.
###end title 63
###begin p 64
###xml 74 75 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 249 255 <span type="species:ncbi:9986">rabbit</span>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
###xml 527 538 <span type="species:ncbi:3704">horseradish</span>
###xml 566 572 <span type="species:ncbi:9986">rabbit</span>
###xml 581 586 <span type="species:ncbi:10090">mouse</span>
Immunoblots of PI3K-p110 isoforms in NK cells were performed. In brief, 106 NK cell lysates were resolved using 10% SDS-PAGE gels and transferred to polyvinylidene fluoride membranes. The blot was probed with the mAbs indicated in the figures. Anti-rabbit PI3K-p110alpha, p110beta, p110gamma, and p110delta, and anti-mouse PI3K-p85alpha mAbs were purchased from Santa Cruz Biotechnology, Inc. Pan-anti-PI3K-p85 mAb was obtained from Millipore, and anti-beta-actin mAb was from Boehringer Mannheim. After incubation with either horseradish peroxidase-conjugated anti-rabbit or anti-mouse mAbs (Santa Cruz Biotechnology, Inc.), membranes were washed and signals were detected using an enhanced chemiluminescence kit (GE Healthcare).
###end p 64
###begin title 65
MAPK activation.
###end title 65
###begin p 66
Cultured NK cells were serum starved for 2 h in PBS and stimulated with plate-bound anti-NKG2D mAb for the time indicated in the figure. Cells were lysed directly in the 96-well plate by the addition of 1 x RIPA buffer (Boston BioProducts) containing protease inhibitors and phosphatase inhibitor cocktails (EMD). Lysates were analyzed for phospho-p38 (Thr180/Tyr182), phospho-ERK1/2 (Thr202/Tyr204), phospho-JNK1/2 (Thr183/Tyr185), respective total proteins, and beta-actin (Cell Signaling Technology) by Western blotting.
###end p 66
###begin title 67
Cytokine and chemokine quantification.
###end title 67
###begin p 68
###xml 292 298 292 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
###xml 537 539 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib75">75</xref>
###xml 1011 1020 991 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN-&#947;</italic>
###xml 1152 1161 1128 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN-&#947;</italic>
###xml 1300 1302 1272 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib76">76</xref>
###xml 1417 1418 1389 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1546 1551 1518 1523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Actin</italic>
###xml 1553 1558 1525 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rps11</italic>
###xml 1564 1571 1536 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tubulin</italic>
###xml 1703 1705 1675 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib76">76</xref>
###xml 1729 1738 1701 1706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN-&#947;</italic>
Fresh or IL-2-cultured, Fc-blocked NK cells were activated with titrated concentrations of plate-bound anti-NKG2D (A10), anti-Ly49D (4E5), and anti-NK1.1 (PK136) mAbs. Where indicated in the figures, NK cells were activated with 2.5 ng/ml IL-12 and 2.5 ng/ml IL-18, or both, in the presence (Fig. 9) or absence (not depicted) of anti-NKG2D mAb (A10). IFN-gamma, GM-CSF, MIP-1alpha, MIP-1beta, and RANTES were quantified using Multiplex kit (Bio-Rad Laboratories). Intracellular cytokines were quantified using established methodologies (75). In brief, NK cells were activated with 10 mug/ml of plate-bound anti-NKG2D (A10) mAb for 12 h in the presence of Brefeldin A for the last 4 h of activation. Activated NK cells were Fc-blocked; stained for NK1.1 alone or in combination with anti-Ly49A, -Ly49D, -Ly49C/I, -Ly49I, or -Ly49G2 mAbs; fixed; permeabilized; and quantified for intracellular IFN-gamma using FITC- (eBioscience) or PE- (BD Biosciences) conjugated anti-IFN-gamma mAbs through flow cytometry. For IFN-gamma encoding mRNA quantification, NK cells were activated for 6 h and harvested for RNA extraction using the RNeasy Mini Kit (QIAGEN). IFN-gamma real-time PCR was performed by using a previously published SYBR green protocol with a thermal cycler (model 7900HT; Applied Biosystems) (76). The transcript in each sample was assayed in triplicate, and the mean cycle threshold was used to calculate the x-fold change and control changes for each gene. Three housekeeping genes were used for global normalization in each experiment (Actin, Rps11, and Tubulin). Data validity by modeling of reaction efficiencies and analysis of measurement precision was determined as described previously (76). Primer sequences for IFN-gamma were 5'-GACTGTGATTGCGGGGTTGT-3' (sense) and 5'-GGCCCGGAGTGTAGACATCT-3' (antisense).
###end p 68
###begin title 69
Drug inhibition assay.
###end title 69
###begin p 70
###xml 132 134 132 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 148 151 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 306 308 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 390 391 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 646 647 639 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
p38 and JNK specific inhibitors SB 202190 and SP600125 (Sigma-Aldrich) were dissolved in DMSO and used in a cytotoxicity assay with 51Cr-labeled EL4H60 or a cytokine stimulation assay using plate-bound anti-NKG2D mAb. Starting concentrations for inhibitors were 20 muM, based on the kinase activity curve (51). In brief, cultured NK cells were harvested and seeded into 96-well plates at 105 cells for the cytotoxicity inhibition assay. Before incubation with target cells, NK cells were treated with SB 202190 or SP600125 for 1 h at 37degreesC, washed, and combined with target cells in a 4-h cytotoxicity assay. For cytokine stimulation, 2 x 105 NK cells/well were seeded directly into 96-well plates that were precoated with anti-NKG2D mAb, followed by the addition of SB 202190 and SP600125 inhibitors. Plates were incubated for 1 h at 37degreesC, washed, and added with 200 mul RPMI 1640 with 10% FBS per well in an 18-h stimulation assay. Potential apoptosis caused by both inhibitors at each concentration was tested by 7-AAD and Annexin V staining.
###end p 70
###begin title 71
Statistics.
###end title 71
###begin p 72
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 177 188 173 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
Statistical analysis was performed with the two-tailed, unpaired Student's t test using Microsoft Excel 2003 software to compare the differences between WT/WT and PI3K-p110deltaD910A/D910A mice. P </= 0.05 was considered significant.
###end p 72
###begin title 73
Online supplemental material.
###end title 73
###begin p 74
###xml 415 426 407 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 500 503 492 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H60</sup>
###xml 605 616 593 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 750 761 734 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D910A/D910A</sup>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows expression levels of early developmental markers in fresh splenic NK cells. Fig. S2 shows normal expression levels of developmental and activation markers in IL-2-activated NK cells. Fig. S3 shows that catalytic inactivation of PI3K-p110delta does not affect the normal expression of MHC class I molecules. Fig. S4 shows that the reduced Ly49C/I NK subset is not caused by cell death in PI3K-p110deltaD910A/D910A mice. Fig. S5 shows that the cytotoxicity of NK cells directed toward EL4H60 is predominantly mediated through the NKG2D receptor. Fig. S6 shows that NK cells from PI3K-p110deltaD910A/D910A mice have decreased abilities to clear tumor cells in vivo. Fig. S7 shows that IL-2-activated BM-derived NK cells from PI3K-p110deltaD910A/D910A mice have a reduced ability to generate cytokines and chemokines. Online supplemental material is available at .
###end p 74
###begin title 75
Supplementary Material
###end title 75
###begin title 76
[Supplemental Material Index]
###end title 76
###begin p 77
We thank Dr. Thomas Moran for influenza virus and help with real-time PCR. The authors thank R. Kamalakannan for help with CD27/CD11b analyses.
###end p 77
###begin p 78
H.Guo is supported by an MCW Cancer Center Postdoctoral Fellowship. This work is supported in part by an American Cancer Society scholar grant (RSG-02-172-LIB), a Roche Organ Transplantation Research Foundation grant (111662730), and a National Institutes of Health grant (R01 A1064826-01 to S. Malarkannan).
###end p 78
###begin p 79
The authors claim no financial conflict of interest.
###end p 79

